{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:58:42Z","timestamp":1789570722848,"version":"build-2803163510"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1001\/jamaneurol.2018.1011","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T19:30:56Z","timestamp":1524511856000},"page":"1071","source":"Crossref","is-referenced-by-count":79,"title":["Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome"],"prefix":"10.1001","volume":"75","author":[{"given":"Hanna G.","family":"Zimmermann","sequence":"first","affiliation":[{"name":"NeuroCure Clinical Research Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Knier","sequence":"additional","affiliation":[{"name":"Department of Neurology, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"},{"name":"Department of Experimental Neuroimmunology, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timm","family":"Oberwahrenbrock","sequence":"additional","affiliation":[{"name":"NeuroCure Clinical Research Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Behrens","sequence":"additional","affiliation":[{"name":"NeuroCure Clinical Research Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherina","family":"Pfuhl","sequence":"additional","affiliation":[{"name":"Department of Neurology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Aly","sequence":"additional","affiliation":[{"name":"Department of Neurology, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"},{"name":"Department of Experimental Neuroimmunology, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Kaminski","sequence":"additional","affiliation":[{"name":"Department of Neurology, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna-Miriam","family":"Hoshi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Specovius","sequence":"additional","affiliation":[{"name":"NeuroCure Clinical Research Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 M.","family":"Giess","sequence":"additional","affiliation":[{"name":"NeuroCure Clinical Research Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Scheel","sequence":"additional","affiliation":[{"name":"NeuroCure Clinical Research Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"M\u00fchlau","sequence":"additional","affiliation":[{"name":"Department of Neurology, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"},{"name":"TUM Neuroimaging Center, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bellmann-Strobl","sequence":"additional","affiliation":[{"name":"NeuroCure Clinical Research Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"},{"name":"Experimental and Clinical Research Center, Max Delbr\u00fcck Center for Molecular Medicine and Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Ruprecht","sequence":"additional","affiliation":[{"name":"Department of Neurology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Hemmer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"},{"name":"Munich Cluster of Systems Neurology (SyNergy), Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Korn","sequence":"additional","affiliation":[{"name":"Department of Neurology, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"},{"name":"Department of Experimental Neuroimmunology, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"},{"name":"Munich Cluster of Systems Neurology (SyNergy), Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[{"name":"NeuroCure Clinical Research Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"},{"name":"Department of Neurology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"},{"name":"Experimental and Clinical Research Center, Max Delbr\u00fcck Center for Molecular Medicine and Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander U.","family":"Brandt","sequence":"additional","affiliation":[{"name":"NeuroCure Clinical Research Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9648","key":"noi180028r1","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis.","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"noi180028r2","doi-asserted-by":"publisher","first-page":"i3518","DOI":"10.1136\/bmj.i3518","article-title":"Disease modifying therapies for relapsing multiple sclerosis.","volume":"354","author":"Wingerchuk","year":"2016","journal-title":"BMJ"},{"issue":"6","key":"noi180028r3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s11940-015-0354-5","article-title":"The transition from first-line to second-line therapy in multiple sclerosis.","volume":"17","author":"D\u00f6rr","year":"2015","journal-title":"Curr Treat Options Neurol"},{"issue":"4","key":"noi180028r4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis.","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol"},{"issue":"2","key":"noi180028r5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"issue":"2","key":"noi180028r6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","article-title":"Clinically isolated syndromes.","volume":"11","author":"Miller","year":"2012","journal-title":"Lancet Neurol"},{"issue":"12","key":"noi180028r7","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00415-016-8302-1","article-title":"Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome.","volume":"263","author":"Huss","year":"2016","journal-title":"J Neurol"},{"issue":"1-2","key":"noi180028r8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jns.2013.03.018","article-title":"Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis.","volume":"329","author":"Hsueh","year":"2013","journal-title":"J Neurol Sci"},{"issue":"pt 3","key":"noi180028r9","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/brain\/awm329","article-title":"Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis.","volume":"131","author":"Fisniku","year":"2008","journal-title":"Brain"},{"issue":"4","key":"noi180028r10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1177\/1352458513496345","article-title":"Clinically isolated syndromes with no further disease activity suggestive of multiple sclerosis at the age of population life expectancy.","volume":"20","author":"Novakova","year":"2014","journal-title":"Mult Scler"},{"issue":"pt 7","key":"noi180028r11","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1093\/brain\/awv105","article-title":"Defining high, medium and low impact prognostic factors for developing multiple sclerosis.","volume":"138","author":"Tintore","year":"2015","journal-title":"Brain"},{"issue":"8","key":"noi180028r12","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1177\/1352458514568827","article-title":"Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.","volume":"21","author":"Kuhle","year":"2015","journal-title":"Mult Scler"},{"key":"noi180028r13","first-page":"153","article-title":"Optical coherence tomography for retinal imaging in multiple sclerosis.","volume":"4","author":"Zimmermann","year":"2014","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"7","key":"noi180028r14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00415-016-8127-y","article-title":"Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.","volume":"263","author":"Balk","year":"2016","journal-title":"J Neurol"},{"issue":"6","key":"noi180028r15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/1352458514567216","article-title":"Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.","volume":"21","author":"Bennett","year":"2015","journal-title":"Mult Scler"},{"issue":"3","key":"noi180028r16","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1212\/NXI.0000000000000334","article-title":"Microstructural visual system changes in AQP4-antibody\u2013seropositive NMOSD.","volume":"4","author":"Oertel","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"noi180028r17","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.v59:6","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography.","volume":"59","author":"Costello","year":"2006","journal-title":"Ann Neurol"},{"issue":"3","key":"noi180028r18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.v77.3","article-title":"Dynamics of retinal injury after acute optic neuritis.","volume":"77","author":"Gabilondo","year":"2015","journal-title":"Ann Neurol"},{"issue":"1","key":"noi180028r19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1001\/jamaneurol.2013.573","article-title":"Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.","volume":"70","author":"Saidha","year":"2013","journal-title":"JAMA Neurol"},{"issue":"5","key":"noi180028r20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.v78.5","article-title":"Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study.","volume":"78","author":"Saidha","year":"2015","journal-title":"Ann Neurol"},{"issue":"6","key":"noi180028r21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S1474-4422(16)00068-5","article-title":"Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.","volume":"15","author":"Martinez-Lapiscina","year":"2016","journal-title":"Lancet Neurol"},{"issue":"11","key":"noi180028r22","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1093\/brain\/aww219","article-title":"Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis.","volume":"139","author":"Knier","year":"2016","journal-title":"Brain"},{"issue":"14","key":"noi180028r23","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1177\/1352458513489757","article-title":"Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.","volume":"19","author":"Oberwahrenbrock","year":"2013","journal-title":"Mult Scler"},{"issue":"7","key":"noi180028r24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1177\/1352458515604496","article-title":"Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination.","volume":"22","author":"Knier","year":"2016","journal-title":"Mult Scler"},{"issue":"2","key":"noi180028r25","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1212\/NXI.0000000000000204","article-title":"Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis.","volume":"3","author":"Metz","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"noi180028r26","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1212\/NXI.0000000000000062","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"Zamvil","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"noi180028r27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1001\/jamaneurol.2014.3537","article-title":"Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort.","volume":"72","author":"Rotstein","year":"2015","journal-title":"JAMA Neurol"},{"issue":"4","key":"noi180028r28","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1016\/j.neuroimage.2011.11.032","article-title":"An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis.","volume":"59","author":"Schmidt","year":"2012","journal-title":"Neuroimage"},{"issue":"4","key":"noi180028r29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time.","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"issue":"10","key":"noi180028r30","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1212\/WNL.0000000000003078","article-title":"The 11-year long-term follow-up study from the randomized BENEFIT CIS trial.","volume":"87","author":"Kappos","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"noi180028r31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ana.24030","article-title":"Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.","volume":"75","author":"Gabilondo","year":"2013","journal-title":"Ann Neurol"},{"issue":"1","key":"noi180028r32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00330-014-3358-8","article-title":"Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning \u2013 an ultrahigh-field MR pilot study.","volume":"25","author":"Sinnecker","year":"2014","journal-title":"Eur Radiol"},{"issue":"4","key":"noi180028r33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/1352458512457844","article-title":"Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.","volume":"19","author":"Zimmermann","year":"2013","journal-title":"Mult Scler"},{"issue":"3","key":"noi180028r34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1212\/WNL.0b013e318220abd4","article-title":"The predictive value of gray matter atrophy in clinically isolated syndromes.","volume":"77","author":"Calabrese","year":"2011","journal-title":"Neurology"},{"issue":"7","key":"noi180028r35","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1177\/1352458514546514","article-title":"Atrophy and structural variability of the upper cervical cord in early multiple sclerosis.","volume":"21","author":"Biberacher","year":"2015","journal-title":"Mult Scler"},{"issue":"5","key":"noi180028r36","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1177\/1352458516663034","article-title":"Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome.","volume":"23","author":"Brownlee","year":"2016","journal-title":"Mult Scler J"},{"issue":"20","key":"noi180028r37","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1212\/01.wnl.0000435551.90824.d0","article-title":"Gray matter damage predicts the accumulation of disability 13 years later in MS.","volume":"81","author":"Filippi","year":"2013","journal-title":"Neurology"},{"issue":"pt 11","key":"noi180028r38","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1093\/brain\/awv258","article-title":"Defining reliable disability outcomes in multiple sclerosis.","volume":"138","author":"Kalincik","year":"2015","journal-title":"Brain"},{"issue":"pt 6","key":"noi180028r39","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/brain\/aws098","article-title":"Microcystic macular oedema in multiple sclerosis is associated with disease severity.","volume":"135","author":"Gelfand","year":"2012","journal-title":"Brain"},{"issue":"11","key":"noi180028r40","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S1474-4422(12)70213-2","article-title":"Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.","volume":"11","author":"Saidha","year":"2012","journal-title":"Lancet Neurol"},{"issue":"8","key":"noi180028r41","doi-asserted-by":"publisher","first-page":"e71145","DOI":"10.1371\/journal.pone.0071145","article-title":"Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis.","volume":"8","author":"Kaufhold","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"noi180028r42","doi-asserted-by":"publisher","first-page":"e0137316","DOI":"10.1371\/journal.pone.0137316","article-title":"Reliability of intra-retinal layer thickness estimates.","volume":"10","author":"Oberwahrenbrock","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"noi180028r43","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1001\/archneurol.2009.265","article-title":"Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss.","volume":"66","author":"Outteryck","year":"2009","journal-title":"Arch Neurol"},{"issue":"1","key":"noi180028r44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/1352458510382017","article-title":"Neither retinal nor brain atrophy can be shown in patients with isolated unilateral optic neuritis at the time of presentation.","volume":"17","author":"Kallenbach","year":"2011","journal-title":"Mult Scler"},{"issue":"5","key":"noi180028r45","doi-asserted-by":"publisher","first-page":"e36847","DOI":"10.1371\/journal.pone.0036847","article-title":"Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes.","volume":"7","author":"Gelfand","year":"2012","journal-title":"PLoS One"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2679108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T15:40:04Z","timestamp":1536594004000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2018.1011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2018.1011","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,1]]}}}